Answers are grounded in this paper and cite their sources.
Cohort study finds longer delays in genomic testing for cancer among low SES and minority populations, indicating necessary policy changes.
In this cohort study, most patients with advanced or metastatic cancers did not undergo tumor genomic testing. Low SES, Black race or Hispanic ethnicity, and Medicaid or Medicare coverage were associated with significantly longer time to NGS, highlighting the need for awareness and health care policies aimed at bridging these gaps.
No takes yet. Share an insight, caveat, or question.
Chehade et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: